Can Making Video Narratives Benefit Adolescents With Cancer

The purpose of this study is to learn more about the content of and benefits of making video testimonials in adolescents with cancer.

Study Overview

• Status: Withdrawn
• Conditions: Pediatric Cancer
• Intervention / Treatment: Behavioral: Video narrative; Behavioral: PedsQL; Behavioral: Ten Item Personality Inventory; Behavioral: Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency Test; Behavioral: The Cognitive Log

Detailed Description

The current research aims to:

A. enlist teens with cancer to produce video narratives about their experiences with their illness B. explicitly characterize and investigate the videos' content and C. determine what aspects of the production were helpful to the teen making them and predicted to be helpful to those watching them.

• Study Type: Interventional
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 11 years to 18 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Diagnosed with cancer
• Patients receiving cancer treatment for the first time
• Can complete study before high school graduation
• Must be able to read and understand English

Exclusion Criteria:

• Participants cannot have been treated for other chronic illnesses prior to cancer diagnosis
• Patients with cognitive and.or verbal capacities impaired to the point where they cannot consent or assent for themselves
• Patients who cannot communicate narratives clearly due to cognitive and/or verbal impairments

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Video Narrative with surveys; Participants will be asked to create a 10-15 minute video narrative on their experiences after being diagnosed with cancer. Participants will also be asked to complete surveys including pediatric quality of life (PedsQL), Ten Item Personality Inventory (TIPI), Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency Test, and The Cognitive Log (Cog-Log)

Behavioral: Video narrative; create a 10-15 minute video intervention about teen experiences after being diagnosed with cancer; Behavioral: PedsQL; A generic 23-item Health Related Quality of Life measure initially developed using pediatric cancer patients; Other Names: Pediatric quality of life; Behavioral: Ten Item Personality Inventory; The TIPI consists of ten items and measures personality based the subject's agreement of descriptions of themselves taken from the Big-5 model of personality; Other Names: TIPI; Behavioral: Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency Test; The D-KEFS Verbal Fluency Test consists of three subtests, which take approximately 6 minutes to complete; Behavioral: The Cognitive Log; The Cog-Log is a 5-10 minute assessment designed to measure basic cognitive functioning and orientation; Other Names: Cog-Log

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
linear regression of pediatric quality of life (PedsQL), TIPI, and coded themes from video narratives on coherence, subjectivity and redemption	Participants' composite scores of the 10 items that make up the emotional and social domains from the PedsQL, 15 items from the PedsQL cancer module, and the two items on the TIPI that measure Extroversion will positively covary with the resilient qualities of their narrative as measured by levels of narrative coherence, subjectivity, and redemption	at end of intervention - Approximately 60 minutes after enrolling on study

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
linear regression of coded resilient qualities of narrative with Post Video Impression Questionnaire	Resilient qualities of the narrative, as measured by levels of narrative coherence, subjectivity, and redemption, will predict the sum of 16 select items on the Post Video Impressions Questionnaire identifying positive impact associated with producing the narrative	at end of intervention - Approximately 60 minutes after enrolling on study
linear regression of impact experienced from making the video narrative with summed scores of participants willingness to post online	The sum of the 16 item composite scale measuring impact experienced from making the testimonial video, on the Post Video Impressions Questionnaire, will positively predict the summed scores of two items measuring participants' willingness to post the video online	at end of intervention - Approximately 60 minutes after enrolling on study
linear regression of perceived impact with summed scores of participants willingness to post the video online	The sum of the 7 item composite scale measuring the perceived impact on others who watch the video, on the Post Video Impressions Questionnaire, will positively predict the summed scores of two items measuring participants' willingness to post the video online	at end of intervention - Approximately 60 minutes after enrolling on study

Collaborators and Investigators

• Sponsor: Case Comprehensive Cancer Center
• Collaborators: MetroHealth Medical Center; Palo Alto University
• Investigators: Principal Investigator: Jennifer C Anderson, PhD, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Study record dates

Study Major Dates

• Study Start (Anticipated): March 5, 2020
• Primary Completion (Anticipated): December 1, 2020
• Study Completion (Anticipated): December 1, 2020

Study Registration Dates

• First Submitted: April 17, 2017
• First Submitted That Met QC Criteria: April 20, 2017
• First Posted (Actual): April 25, 2017

Study Record Updates

• Last Update Posted (Actual): April 9, 2020
• Last Update Submitted That Met QC Criteria: April 8, 2020
• Last Verified: April 1, 2020

More Information

Terms related to this study

• Keywords: Video Narrative
• Other Study ID Numbers: CASE12Z16

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No